GALC (galactocerebrosidase / galactosylceramidase; EC 3.2.1.46) is a lysosomal glycoside hydrolase of the GH59 family that catabolizes galactolipids. It hydrolyzes the terminal galactose from galactosylceramide (galactocerebroside) to yield ceramide plus D-galactose, and also hydrolyzes galactosylsphingosine (psychosine) and related galactolipids. Acting at acidic pH in the lysosome/lysosomal lumen, the soluble enzyme depends on the lipid-transfer protein saposin A (derived from prosaposin, PSAP), which presents the membrane-embedded glycosphingolipid substrate to the GALC active site. Galactosylceramide is a major lipid of the myelin sheath, so GALC is central to myelin glycosphingolipid turnover. Loss of GALC activity causes Krabbe disease (globoid cell leukodystrophy), an autosomal recessive lysosomal storage disorder in which accumulation of the cytotoxic substrate psychosine drives demyelination and neurodegeneration.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004336
galactosylceramidase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic (PAN-GO) transfer of the defining molecular function of GALC. GALC is a GH59 galactosylceramidase (EC 3.2.1.46) that hydrolyzes the terminal galactose from galactosylceramide; this is the biochemically demonstrated core activity of the human enzyme.
Reason: This is the correct, specific molecular function for GALC and represents its core catalytic activity. It is directly supported by biochemistry on the purified human enzyme and cDNA expression, and is consistent across the phylogenetic tree.
Supporting Evidence:
PMID:8399327
Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine
file:human/GALC/GALC-uniprot.txt
Hydrolyzes the galactose ester bonds of glycolipids such as
|
|
GO:0005764
lysosome
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic transfer of lysosomal localization. GALC is a soluble acid hydrolase that acts in the lysosome; UniProt subcellular location is Lysosome and the enzyme has an acidic pH optimum consistent with lysosomal function.
Reason: Lysosome is the correct site of action for GALC and is well supported. Retained as a core localization for this lysosomal enzyme.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
PMID:7601472
catalyzes the lysosomal hydrolysis of specific galactolipids
|
|
GO:0006683
galactosylceramide catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic transfer of the core biological process. By hydrolyzing galactosylceramide to ceramide and galactose, GALC executes the lysosomal galactosylceramide catabolic process.
Reason: This is the precise biological process for GALC's catalytic activity and is its core role. Retained as a core function.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
PMID:15657896
galactosylcerebroside to ceramide
|
|
GO:0004336
galactosylceramidase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (ARBA/InterPro/RHEA/EC) assignment of galactosylceramidase activity, mapping GALC (GH59 family, EC 3.2.1.46, RHEA:14297) to its defining molecular function.
Reason: The electronic mapping is correct and matches the experimentally verified core activity; the same term is independently supported by IDA and IBA.
Supporting Evidence:
file:human/GALC/GALC-uniprot.txt
Belongs to the glycosyl hydrolase 59 family
|
|
GO:0005764
lysosome
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: UniProt SubCellular-location keyword mapping to lysosome, consistent with the curated UniProt subcellular location (Lysosome) for this acid hydrolase.
Reason: Lysosomal localization is correct and independently supported (IBA, TAS). Kept as a core localization.
Supporting Evidence:
PMID:7601472
catalyzes the lysosomal hydrolysis of specific galactolipids
|
|
GO:0006683
galactosylceramide catabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated (ARBA/InterPro) assignment of galactosylceramide catabolic process, the precise biological process executed by GALC's hydrolase activity.
Reason: Correct electronic mapping matching the experimentally supported core process; also supported by IDA, IBA and ISS.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
|
|
GO:0006683
galactosylceramide catabolic process
|
IDA
PMID:15657896 Implications of galactocerebrosidase and galactosylcerebrosi... |
ACCEPT |
Summary: Galactosylceramide catabolic process supported by a review of GALC/GalCer metabolism in cancer, which describes GALC as the enzyme degrading galactosylcerebroside to ceramide. The biology (GALC breaks down galactosylceramide) is correct.
Reason: The annotated process is the correct core process for GALC. The cited reference is a review (annotated IDA), so it is not the strongest primary evidence, but the same process is robustly supported by primary biochemistry (PMID:8281145, PMID:8399327) and by IBA. Per curation policy, the experimental annotation is retained rather than removed.
Supporting Evidence:
PMID:15657896
the enzyme responsible for degrading
PMID:15657896
galactosylcerebroside to ceramide
|
|
GO:0004336
galactosylceramidase activity
|
IDA
PMID:8281145 Cloning and expression of cDNA encoding human galactocerebro... |
ACCEPT |
Summary: Direct assay of galactosylceramidase activity. The human GALC cDNA was cloned and expressed in COS-1 cells, yielding GALC enzyme activity; the enzyme is defined as responsible for lysosomal catabolism of galactosylceramide. This is the primary experimental basis for the core molecular function.
Reason: Direct experimental support (cDNA expression conferring GALC activity) for the core catalytic function; represents the defining molecular function of the gene.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
|
|
GO:0004336
galactosylceramidase activity
|
IDA
PMID:8281145 Cloning and expression of cDNA encoding human galactocerebro... |
ACCEPT |
Summary: Direct assay of galactosylceramidase activity (duplicate GOA record from a different assigning group, same term/evidence/reference). Human GALC cDNA expression confers GALC enzyme activity, defining the core molecular function.
Reason: Duplicate of the direct-evidence galactosylceramidase-activity annotation; same correct core molecular function. Retained.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
|
|
GO:0036021
endolysosome lumen
|
IC
PMID:27498570 Endolysosomes Are the Principal Intracellular Sites of Acid ... |
KEEP AS NON CORE |
Summary: Curator inference (IC) placing GALC's activity in the endolysosome lumen, derived from its acid-hydrolase molecular function (GO:0004336) together with the general finding that endolysosomes are the principal intracellular sites of acid hydrolase activity. The cited paper is a general endolysosome study and does not assay GALC specifically.
Reason: Reasonable and biologically consistent refinement of the lysosomal localization, but it is an inference from a general acid-hydrolase study rather than GALC-specific evidence. The core, best-supported localization for GALC is the lysosome/lysosomal lumen; kept as a non-core, more granular localization.
Supporting Evidence:
PMID:27498570
endolysosomes are the principal organelles in which substrates are hydrolyzed
|
|
GO:0036021
endolysosome lumen
|
IC
PMID:29323104 The mechanism of glycosphingolipid degradation revealed by a... |
KEEP AS NON CORE |
Summary: Curator inference (IC) that GALC is active in the endolysosome lumen, supported by the GALC-SapA complex study showing that GALC-mediated glycosphingolipid degradation occurs at low pH equivalent to the late-endosomal/lysosomal (endolysosomal) compartment and requires saposin A.
Reason: The endolysosomal context is well grounded in this GALC-specific structural and biochemical study, but at the granularity used by this project the core localization is the lysosome/lysosomal lumen. Retained as a non-core, more granular localization.
Supporting Evidence:
PMID:29323104
responsible for the removal of the terminal galactose from the glycosphingolipid galactocerebroside
PMID:29323104
This enzyme requires the saposin SapA for lipid
|
|
GO:0046479
glycosphingolipid catabolic process
|
TAS
Reactome:R-HSA-9840310 |
KEEP AS NON CORE |
Summary: Reactome pathway annotation placing GALC in glycosphingolipid catabolism. Galactosylceramide is a glycosphingolipid, so this is a correct but broader-than-precise parent process relative to galactosylceramide catabolic process.
Reason: Correct but more general than the precise core term (GO:0006683 galactosylceramide catabolic process). Retained as a valid non-core, higher-level pathway annotation.
Supporting Evidence:
PMID:29323104
responsible for the removal of the terminal galactose from the glycosphingolipid galactocerebroside
|
|
GO:0030149
sphingolipid catabolic process
|
IDA
PMID:8281145 Cloning and expression of cDNA encoding human galactocerebro... |
KEEP AS NON CORE |
Summary: Sphingolipid catabolic process, a broad parent of the precise galactosylceramide catabolic process. GALC catabolizes galactosylceramide (a glycosphingolipid) and galactosylsphingosine, so it acts in sphingolipid catabolism.
Reason: Correct but less specific than the core term (GO:0006683 galactosylceramide catabolic process). Retained as a valid non-core, higher-level process annotation.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
|
|
GO:0004336
galactosylceramidase activity
|
TAS
Reactome:R-HSA-1606564 |
ACCEPT |
Summary: Reactome traceable assertion of galactosylceramidase activity (reaction "GALC hydrolyzes GalCer"), matching the defining, experimentally verified core molecular function of GALC.
Reason: Correct core molecular function, independently supported by IDA and IBA. Retained as core.
Supporting Evidence:
PMID:8399327
Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine
|
|
GO:0004336
galactosylceramidase activity
|
IDA
PMID:8399327 Galactocerebrosidase from human urine: purification and part... |
ACCEPT |
Summary: Direct biochemical characterization of galactosylceramidase activity. GALC (EC 3.2.1.46) was purified ~176,000-fold from human urine (and brain, placenta) with an acidic pH optimum (4.0-4.4) and KM=10 uM for N-acyl-beta-D-galactosylsphingosine, directly demonstrating the enzyme's activity.
Reason: Strong direct experimental evidence for the core molecular function of GALC on the purified human enzyme. Retained as core.
Supporting Evidence:
PMID:8399327
Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine
|
|
GO:0006683
galactosylceramide catabolic process
|
IDA
PMID:8399327 Galactocerebrosidase from human urine: purification and part... |
ACCEPT |
Summary: Galactosylceramide catabolic process supported by direct characterization of the purified human enzyme, which is deficient in Krabbe disease and cleaves galactolipid substrates. This is the precise core biological process for GALC.
Reason: Direct experimental support for the core catabolic process of GALC. Retained as core.
Supporting Evidence:
PMID:8399327
Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine
|
|
GO:0004336
galactosylceramidase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of galactosylceramidase activity from the mouse ortholog (UniProtKB:P54818). GALC is a conserved GH59 galactosylceramidase.
Reason: The ortholog-based transfer is correct and redundant with the direct experimental (IDA) and IBA support for the same core molecular function.
Supporting Evidence:
file:human/GALC/GALC-uniprot.txt
Belongs to the glycosyl hydrolase 59 family
|
|
GO:0006683
galactosylceramide catabolic process
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: Sequence-similarity transfer of galactosylceramide catabolic process from the mouse ortholog (UniProtKB:P54818), matching GALC's precise core biological process.
Reason: Correct ortholog-based transfer, redundant with direct (IDA) and IBA support for the same core process.
Supporting Evidence:
PMID:8281145
responsible for the lysosomal catabolism of galactosylceramide, a major lipid in
|
|
GO:0043202
lysosomal lumen
|
TAS
Reactome:R-HSA-1606564 |
ACCEPT |
Summary: Reactome traceable assertion localizing GALC to the lysosomal lumen, the compartment where the soluble acid hydrolase acts on its substrate.
Reason: Correct and specific localization of this soluble lysosomal hydrolase to the lysosomal lumen. Retained as a core localization.
Supporting Evidence:
PMID:7601472
catalyzes the lysosomal hydrolysis of specific galactolipids
|
|
GO:0005764
lysosome
|
TAS
PMID:7601472 Structure and organization of the human galactocerebrosidase... |
ACCEPT |
Summary: Lysosome localization asserted from the literature. The GALC gene-structure paper describes the enzyme as catalyzing lysosomal hydrolysis of galactolipids, consistent with a lysosomal acid hydrolase.
Reason: Correct core localization, independently supported by IBA and Reactome TAS. Retained as core.
Supporting Evidence:
PMID:7601472
catalyzes the lysosomal hydrolysis of specific galactolipids
|
UniProt: P54803 (GALC_HUMAN); HGNC:4115; EC 3.2.1.46; gene on chr14.
Glycosyl hydrolase family GH59 (CAZy GH59; Pfam PF02057).
GALC is a lysosomal glycosidase of glycosphingolipid catabolism. It hydrolyses the
terminal galactose from galactosylceramide (galactocerebroside) to yield ceramide +
D-galactose (EC 3.2.1.46, RHEA:14297), and also hydrolyses galactosylsphingosine
(psychosine) and other galactolipids.
Requires saposin A (SapA, from PSAP) for lipid presentation. GALC-SapA crystal
structure (murine) = 2:2 heterotetramer; open channel from GALC active site to SapA
hydrophobic cavity presents the polar glycosyl headgroup to the active site while shielding
the acyl chains. "This enzyme requires the saposin SapA for lipid processing and defects in
either of these proteins causes a severe neurodegenerative disorder, Krabbe disease"
PMID:29323104. Active-site residues (UniProt): proton donor/acceptor His... actually
ACT_SITE 198 (proton donor/acceptor), 274 (nucleophile). GH59 retaining glycosidase.
Lysosome / lysosomal lumen. GO IC annotations place it in endolysosome lumen (GO:0036021),
inferred from the general finding that endolysosomes are the principal sites of acid
hydrolase activity PMID:27498570 combined with GALC's acid-hydrolase MF (GO:0004336).
PMID:27498570 is a general endolysosome study and does NOT mention GALC by name; the
endolysosome-lumen call is a curator inference (IC). Lysosome localization is well
established (subcellular location "Lysosome"; typical acid hydrolase, mannose-6-phosphate
pathway implied).
Deficiency causes Krabbe disease / globoid cell leukodystrophy (KRB; MIM:245200),
autosomal recessive. Psychosine (galactosylsphingosine) accumulation is neurotoxic and
drives demyelination. Many pathogenic missense variants across the gene (UniProt lists
dozens of KRB variants). Four clinical forms; infantile form ~90% of cases.
GOA MF term present and current: GO:0004336 galactosylceramidase activity (verified via
OLS, not obsolete). This is the core MF used in core_functions.
Core BP: GO:0006683 galactosylceramide catabolic process (verified current).
Locations: GO:0005764 lysosome, GO:0043202 lysosomal lumen (both verified current).
Notes on individual annotations:
- PMID:15657896 is a review on GALC in cancer, annotated IDA to GO:0006683. IDA on a
review is unusual, but it does correctly describe GALC degrading galactosylcerebroside to
ceramide. Not a core-defining primary experiment; keep as non-core / accept the biology
but flag the evidence type. Per policy do NOT REMOVE (can't see full curator context) —
accept the biology, note the review nature.
- GO:0030149 sphingolipid catabolic process (IDA, PMID:8281145): broader parent-type BP;
GALC does act in sphingolipid catabolism (galactosylceramide is a glycosphingolipid).
Keep as non-core (galactosylceramide catabolic process is the precise term).
- GO:0046479 glycosphingolipid catabolic process (TAS, Reactome): correct, broader than the
precise galactosylceramide catabolic process; keep as non-core.
- Reactome/GO_REF/IEA/ISS/IBA MF and BP annotations all consistent; accept.
Falcon deep research is OUT OF CREDITS (HTTP 402) — no -deep-research-falcon.md generated.
Review grounded in GALC-uniprot.txt, GALC-goa.tsv, and cached publications/PMID_*.md.
id: P54803
gene_symbol: GALC
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: GALC (galactocerebrosidase / galactosylceramidase; EC 3.2.1.46) is a lysosomal
glycoside hydrolase of the GH59 family that catabolizes galactolipids. It hydrolyzes the
terminal galactose from galactosylceramide (galactocerebroside) to yield ceramide plus
D-galactose, and also hydrolyzes galactosylsphingosine (psychosine) and related
galactolipids. Acting at acidic pH in the lysosome/lysosomal lumen, the soluble enzyme
depends on the lipid-transfer protein saposin A (derived from prosaposin, PSAP), which
presents the membrane-embedded glycosphingolipid substrate to the GALC active site.
Galactosylceramide is a major lipid of the myelin sheath, so GALC is central to myelin
glycosphingolipid turnover. Loss of GALC activity causes Krabbe disease (globoid cell
leukodystrophy), an autosomal recessive lysosomal storage disorder in which accumulation
of the cytotoxic substrate psychosine drives demyelination and neurodegeneration.
alternative_products:
- name: '1'
id: P54803-1
- name: '3'
id: P54803-3
sequence_note: VSP_036976
- name: '4'
id: P54803-4
sequence_note: VSP_036974
- name: '5'
id: P54803-5
sequence_note: VSP_036975, VSP_036977
existing_annotations:
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetic (PAN-GO) transfer of the defining molecular function of GALC.
GALC is a GH59 galactosylceramidase (EC 3.2.1.46) that hydrolyzes the terminal
galactose from galactosylceramide; this is the biochemically demonstrated core
activity of the human enzyme.
action: ACCEPT
reason: This is the correct, specific molecular function for GALC and represents its
core catalytic activity. It is directly supported by biochemistry on the purified
human enzyme and cDNA expression, and is consistent across the phylogenetic tree.
supported_by:
- reference_id: PMID:8399327
supporting_text: "Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine"
- reference_id: file:human/GALC/GALC-uniprot.txt
supporting_text: "Hydrolyzes the galactose ester bonds of glycolipids such as"
- term:
id: GO:0005764
label: lysosome
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Phylogenetic transfer of lysosomal localization. GALC is a soluble acid
hydrolase that acts in the lysosome; UniProt subcellular location is Lysosome and the
enzyme has an acidic pH optimum consistent with lysosomal function.
action: ACCEPT
reason: Lysosome is the correct site of action for GALC and is well supported. Retained
as a core localization for this lysosomal enzyme.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- reference_id: PMID:7601472
supporting_text: "catalyzes the lysosomal hydrolysis of specific galactolipids"
- term:
id: GO:0006683
label: galactosylceramide catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetic transfer of the core biological process. By hydrolyzing
galactosylceramide to ceramide and galactose, GALC executes the lysosomal
galactosylceramide catabolic process.
action: ACCEPT
reason: This is the precise biological process for GALC's catalytic activity and is its
core role. Retained as a core function.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- reference_id: PMID:15657896
supporting_text: "galactosylcerebroside to ceramide"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated (ARBA/InterPro/RHEA/EC) assignment of galactosylceramidase activity,
mapping GALC (GH59 family, EC 3.2.1.46, RHEA:14297) to its defining molecular function.
action: ACCEPT
reason: The electronic mapping is correct and matches the experimentally verified core
activity; the same term is independently supported by IDA and IBA.
supported_by:
- reference_id: file:human/GALC/GALC-uniprot.txt
supporting_text: "Belongs to the glycosyl hydrolase 59 family"
- term:
id: GO:0005764
label: lysosome
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: UniProt SubCellular-location keyword mapping to lysosome, consistent with the
curated UniProt subcellular location (Lysosome) for this acid hydrolase.
action: ACCEPT
reason: Lysosomal localization is correct and independently supported (IBA, TAS). Kept
as a core localization.
supported_by:
- reference_id: PMID:7601472
supporting_text: "catalyzes the lysosomal hydrolysis of specific galactolipids"
- term:
id: GO:0006683
label: galactosylceramide catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: Automated (ARBA/InterPro) assignment of galactosylceramide catabolic process,
the precise biological process executed by GALC's hydrolase activity.
action: ACCEPT
reason: Correct electronic mapping matching the experimentally supported core process;
also supported by IDA, IBA and ISS.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- term:
id: GO:0006683
label: galactosylceramide catabolic process
evidence_type: IDA
original_reference_id: PMID:15657896
qualifier: involved_in
review:
summary: Galactosylceramide catabolic process supported by a review of GALC/GalCer
metabolism in cancer, which describes GALC as the enzyme degrading galactosylcerebroside
to ceramide. The biology (GALC breaks down galactosylceramide) is correct.
action: ACCEPT
reason: The annotated process is the correct core process for GALC. The cited reference
is a review (annotated IDA), so it is not the strongest primary evidence, but the same
process is robustly supported by primary biochemistry (PMID:8281145, PMID:8399327) and
by IBA. Per curation policy, the experimental annotation is retained rather than removed.
supported_by:
- reference_id: PMID:15657896
supporting_text: "the enzyme responsible for degrading"
- reference_id: PMID:15657896
supporting_text: "galactosylcerebroside to ceramide"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: IDA
original_reference_id: PMID:8281145
qualifier: enables
review:
summary: Direct assay of galactosylceramidase activity. The human GALC cDNA was cloned
and expressed in COS-1 cells, yielding GALC enzyme activity; the enzyme is defined as
responsible for lysosomal catabolism of galactosylceramide. This is the primary
experimental basis for the core molecular function.
action: ACCEPT
reason: Direct experimental support (cDNA expression conferring GALC activity) for the
core catalytic function; represents the defining molecular function of the gene.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: IDA
original_reference_id: PMID:8281145
qualifier: enables
review:
summary: Direct assay of galactosylceramidase activity (duplicate GOA record from a
different assigning group, same term/evidence/reference). Human GALC cDNA expression
confers GALC enzyme activity, defining the core molecular function.
action: ACCEPT
reason: Duplicate of the direct-evidence galactosylceramidase-activity annotation; same
correct core molecular function. Retained.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- term:
id: GO:0036021
label: endolysosome lumen
evidence_type: IC
original_reference_id: PMID:27498570
qualifier: is_active_in
review:
summary: Curator inference (IC) placing GALC's activity in the endolysosome lumen,
derived from its acid-hydrolase molecular function (GO:0004336) together with the
general finding that endolysosomes are the principal intracellular sites of acid
hydrolase activity. The cited paper is a general endolysosome study and does not assay
GALC specifically.
action: KEEP_AS_NON_CORE
reason: Reasonable and biologically consistent refinement of the lysosomal localization,
but it is an inference from a general acid-hydrolase study rather than GALC-specific
evidence. The core, best-supported localization for GALC is the lysosome/lysosomal
lumen; kept as a non-core, more granular localization.
supported_by:
- reference_id: PMID:27498570
supporting_text: "endolysosomes are the principal organelles in which substrates are hydrolyzed"
- term:
id: GO:0036021
label: endolysosome lumen
evidence_type: IC
original_reference_id: PMID:29323104
qualifier: is_active_in
review:
summary: Curator inference (IC) that GALC is active in the endolysosome lumen, supported
by the GALC-SapA complex study showing that GALC-mediated glycosphingolipid degradation
occurs at low pH equivalent to the late-endosomal/lysosomal (endolysosomal) compartment
and requires saposin A.
action: KEEP_AS_NON_CORE
reason: The endolysosomal context is well grounded in this GALC-specific structural and
biochemical study, but at the granularity used by this project the core localization is
the lysosome/lysosomal lumen. Retained as a non-core, more granular localization.
supported_by:
- reference_id: PMID:29323104
supporting_text: "responsible for the removal of the terminal galactose from the glycosphingolipid galactocerebroside"
- reference_id: PMID:29323104
supporting_text: "This enzyme requires the saposin SapA for lipid"
- term:
id: GO:0046479
label: glycosphingolipid catabolic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9840310
qualifier: involved_in
review:
summary: Reactome pathway annotation placing GALC in glycosphingolipid catabolism.
Galactosylceramide is a glycosphingolipid, so this is a correct but broader-than-precise
parent process relative to galactosylceramide catabolic process.
action: KEEP_AS_NON_CORE
reason: Correct but more general than the precise core term (GO:0006683 galactosylceramide
catabolic process). Retained as a valid non-core, higher-level pathway annotation.
supported_by:
- reference_id: PMID:29323104
supporting_text: "responsible for the removal of the terminal galactose from the glycosphingolipid galactocerebroside"
- term:
id: GO:0030149
label: sphingolipid catabolic process
evidence_type: IDA
original_reference_id: PMID:8281145
qualifier: involved_in
review:
summary: Sphingolipid catabolic process, a broad parent of the precise galactosylceramide
catabolic process. GALC catabolizes galactosylceramide (a glycosphingolipid) and
galactosylsphingosine, so it acts in sphingolipid catabolism.
action: KEEP_AS_NON_CORE
reason: Correct but less specific than the core term (GO:0006683 galactosylceramide
catabolic process). Retained as a valid non-core, higher-level process annotation.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1606564
qualifier: enables
review:
summary: Reactome traceable assertion of galactosylceramidase activity (reaction "GALC
hydrolyzes GalCer"), matching the defining, experimentally verified core molecular
function of GALC.
action: ACCEPT
reason: Correct core molecular function, independently supported by IDA and IBA. Retained
as core.
supported_by:
- reference_id: PMID:8399327
supporting_text: "Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: IDA
original_reference_id: PMID:8399327
qualifier: enables
review:
summary: Direct biochemical characterization of galactosylceramidase activity. GALC
(EC 3.2.1.46) was purified ~176,000-fold from human urine (and brain, placenta) with
an acidic pH optimum (4.0-4.4) and KM=10 uM for N-acyl-beta-D-galactosylsphingosine,
directly demonstrating the enzyme's activity.
action: ACCEPT
reason: Strong direct experimental evidence for the core molecular function of GALC on
the purified human enzyme. Retained as core.
supported_by:
- reference_id: PMID:8399327
supporting_text: "Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine"
- term:
id: GO:0006683
label: galactosylceramide catabolic process
evidence_type: IDA
original_reference_id: PMID:8399327
qualifier: involved_in
review:
summary: Galactosylceramide catabolic process supported by direct characterization of the
purified human enzyme, which is deficient in Krabbe disease and cleaves galactolipid
substrates. This is the precise core biological process for GALC.
action: ACCEPT
reason: Direct experimental support for the core catabolic process of GALC. Retained as
core.
supported_by:
- reference_id: PMID:8399327
supporting_text: "Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine"
- term:
id: GO:0004336
label: galactosylceramidase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: Sequence-similarity transfer of galactosylceramidase activity from the mouse
ortholog (UniProtKB:P54818). GALC is a conserved GH59 galactosylceramidase.
action: ACCEPT
reason: The ortholog-based transfer is correct and redundant with the direct
experimental (IDA) and IBA support for the same core molecular function.
supported_by:
- reference_id: file:human/GALC/GALC-uniprot.txt
supporting_text: "Belongs to the glycosyl hydrolase 59 family"
- term:
id: GO:0006683
label: galactosylceramide catabolic process
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: involved_in
review:
summary: Sequence-similarity transfer of galactosylceramide catabolic process from the
mouse ortholog (UniProtKB:P54818), matching GALC's precise core biological process.
action: ACCEPT
reason: Correct ortholog-based transfer, redundant with direct (IDA) and IBA support for
the same core process.
supported_by:
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- term:
id: GO:0043202
label: lysosomal lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-1606564
qualifier: located_in
review:
summary: Reactome traceable assertion localizing GALC to the lysosomal lumen, the
compartment where the soluble acid hydrolase acts on its substrate.
action: ACCEPT
reason: Correct and specific localization of this soluble lysosomal hydrolase to the
lysosomal lumen. Retained as a core localization.
supported_by:
- reference_id: PMID:7601472
supporting_text: "catalyzes the lysosomal hydrolysis of specific galactolipids"
- term:
id: GO:0005764
label: lysosome
evidence_type: TAS
original_reference_id: PMID:7601472
qualifier: located_in
review:
summary: Lysosome localization asserted from the literature. The GALC gene-structure
paper describes the enzyme as catalyzing lysosomal hydrolysis of galactolipids,
consistent with a lysosomal acid hydrolase.
action: ACCEPT
reason: Correct core localization, independently supported by IBA and Reactome TAS.
Retained as core.
supported_by:
- reference_id: PMID:7601472
supporting_text: "catalyzes the lysosomal hydrolysis of specific galactolipids"
core_functions:
- description: >-
Lysosomal galactosylceramidase (galactocerebrosidase, EC 3.2.1.46): a soluble GH59
acid hydrolase that removes the terminal galactose from galactosylceramide
(galactocerebroside) to yield ceramide and D-galactose, and also hydrolyzes
galactosylsphingosine (psychosine) and related galactolipids. It thereby carries out the
lysosomal galactosylceramide catabolic step of glycosphingolipid degradation, acting on
membrane-embedded substrate presented by saposin A (from PSAP). Galactosylceramide is a
major myelin lipid, and loss of this activity causes Krabbe disease (globoid cell
leukodystrophy).
molecular_function:
id: GO:0004336
label: galactosylceramidase activity
directly_involved_in:
- id: GO:0006683
label: galactosylceramide catabolic process
locations:
- id: GO:0043202
label: lysosomal lumen
- id: GO:0005764
label: lysosome
supported_by:
- reference_id: PMID:8399327
supporting_text: "Galactocerebrosidase (GALC, EC 3.2.1.46) was purified from human urine"
- reference_id: PMID:8281145
supporting_text: "responsible for the lysosomal catabolism of galactosylceramide, a major lipid in"
- reference_id: PMID:7601472
supporting_text: "catalyzes the lysosomal hydrolysis of specific galactolipids"
- reference_id: PMID:29323104
supporting_text: "This enzyme requires the saposin SapA for lipid"
- reference_id: file:human/GALC/GALC-uniprot.txt
supporting_text: "Hydrolyzes the galactose ester bonds of glycolipids such as"
references:
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:15657896
title: Implications of galactocerebrosidase and galactosylcerebroside metabolism
in cancer cells.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: PubMed-verified review describing GALC as the enzyme degrading
galactosylcerebroside to ceramide. Correctly supports the catabolic role but is a
review (used as IDA in GOA), so it corroborates rather than establishes the core
function.
- id: PMID:27498570
title: Endolysosomes Are the Principal Intracellular Sites of Acid Hydrolase Activity.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: PubMed-verified general study establishing that endolysosomes are the
principal sites of acid hydrolase activity. It does not assay GALC; it underpins the
curator (IC) inference for GALC's endolysosome-lumen localization only indirectly.
- id: PMID:29323104
title: The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex
structure.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified. GALC-SapA complex structure defining the saposin-A
dependent mechanism of galactocerebroside cleavage in the endolysosomal compartment.
Directly relevant to GALC's mechanism and localization.
- id: PMID:7601472
title: Structure and organization of the human galactocerebrosidase (GALC) gene.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified. Gene-structure paper that also states GALC catalyzes
lysosomal hydrolysis of galactolipids including galactosylceramide and
galactosylsphingosine (psychosine); supports catalytic function and lysosomal
localization.
- id: PMID:8281145
title: Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme
deficient in globoid cell leukodystrophy.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified primary paper cloning and expressing human GALC cDNA;
establishes GALC as responsible for lysosomal catabolism of galactosylceramide.
- id: PMID:8399327
title: 'Galactocerebrosidase from human urine: purification and partial characterization.'
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: PubMed-verified primary biochemistry; purification and enzymatic
characterization of human GALC (EC 3.2.1.46), including acid pH optimum and KM.
Direct support for the core molecular function.
- id: Reactome:R-HSA-1606564
title: GALC hydrolyzes GalCer
findings: []
- id: Reactome:R-HSA-9840310
title: Glycosphingolipid catabolism
findings: []
- id: file:human/GALC/GALC-uniprot.txt
title: UniProtKB P54803 (GALC_HUMAN) record
findings: []